Total Payments
$955.42
2024 Payments
$456.99
Companies
10
Transactions
37
Medicare Patients
960
Medicare Billing
$90,796
Payment Breakdown by Category
Food & Beverage$955.42 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $955.42 | 37 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $309.37 | 14 | $0 (2024) |
| GENZYME CORPORATION | $184.68 | 6 | $0 (2024) |
| Optinose US, Inc. | $102.56 | 4 | $0 (2024) |
| kaleo, Inc. | $93.36 | 4 | $0 (2023) |
| Amgen Inc. | $85.05 | 3 | $0 (2023) |
| Hikma Pharmaceuticals USA | $68.98 | 2 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $31.67 | 1 | $0 (2024) |
| Boston Scientific Corporation | $28.68 | 1 | $0 (2022) |
| Pharming Healthcare, Inc. | $27.67 | 1 | $0 (2024) |
| Phadia US Inc. | $23.40 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $456.99 | 18 | GlaxoSmithKline, LLC. ($173.71) |
| 2023 | $445.05 | 17 | GlaxoSmithKline, LLC. ($135.66) |
| 2022 | $53.38 | 2 | Boston Scientific Corporation ($28.68) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.97 | General |
| Category: Immunology | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: BIOLOGIC | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $31.67 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/03/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: IMMUNOLOGY | ||||||
| 07/22/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: IMMUNOLOGY | ||||||
| 07/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: Immunology | ||||||
| 06/19/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 06/04/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: IMMUNOLOGY | ||||||
| 05/20/2024 | Hikma Pharmaceuticals USA | Ryaltris (Drug) | Food and Beverage | In-kind items and services | $50.50 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 04/29/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 04/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Immunology | ||||||
| 04/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: IMMUNOLOGY | ||||||
| 04/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $1.49 | General |
| Category: IMMUNOLOGY | ||||||
| 04/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $1.40 | General |
| Category: IMMUNOLOGY | ||||||
| 04/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $38.41 | General |
| Category: Immunology | ||||||
| 01/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $28.64 | General |
| Category: IMMUNOLOGY | ||||||
| 12/27/2023 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Allergy | ||||||
| 12/11/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Immunology | ||||||
| 12/03/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: IMMUNOLOGY | ||||||
| 11/28/2023 | kaleo, Inc. | AUVI-Q (Drug) | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: Allergy | ||||||
| 11/20/2023 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Inflammation | ||||||
| 11/06/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2023 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $30.14 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 642 | 692 | $201,718 | $61,627 |
| 2022 | 7 | 318 | 340 | $84,365 | $29,170 |
Total Patients
960
Total Services
1,032
Medicare Billing
$90,796
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 99 | 108 | $82,728 | $17,398 | 21.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 166 | 166 | $33,200 | $15,428 | 46.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 137 | 165 | $35,805 | $12,408 | 34.7% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 42 | 42 | $12,180 | $4,776 | 39.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 29 | $6,525 | $3,202 | 49.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $7,200 | $3,077 | 42.7% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2023 | 72 | 73 | $7,957 | $2,663 | 33.5% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 51 | 57 | $14,043 | $1,961 | 14.0% |
| 92504 | Exam of ear using a microscope | Office | 2023 | 30 | 32 | $2,080 | $715.52 | 34.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 91 | 91 | $18,200 | $9,220 | 50.7% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 37 | 39 | $29,874 | $7,367 | 24.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 70 | 82 | $17,794 | $6,659 | 37.4% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 14 | 14 | $4,060 | $1,800 | 44.3% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2022 | 30 | 30 | $3,270 | $1,403 | 42.9% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 32 | 33 | $7,852 | $1,371 | 17.5% |
| 92504 | Exam of ear using a microscope | Office | 2022 | 44 | 51 | $3,315 | $1,350 | 40.7% |
About Dr. Ankit Kansal, M.D
Dr. Ankit Kansal, M.D is a Otolaryngology healthcare provider based in Astoria, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2017. The National Provider Identifier (NPI) number assigned to this provider is 1467985044.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ankit Kansal, M.D has received a total of $955.42 in payments from pharmaceutical and medical device companies, with $456.99 received in 2024. These payments were reported across 37 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($955.42).
As a Medicare-enrolled provider, Kansal has provided services to 960 Medicare beneficiaries, totaling 1,032 services with total Medicare billing of $90,796. Data is available for 2 years (2022–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Otolaryngology
- Location Astoria, NY
- Active Since 04/10/2017
- Last Updated 08/19/2022
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1467985044
Products in Payments
- NUCALA (Biological) $309.37
- DUPIXENT (Biological) $184.68
- Xhance (Drug) $102.56
- AUVI-Q (Drug) $93.36
- TEZSPIRE (Biological) $85.05
- Ryaltris (Drug) $68.98
- EOHILIA (Drug) $31.67
- General - Kidney Stone Disease (Device) $28.68
- RUCONEST (Biological) $27.67
- ImmunoCAP (Device) $23.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Otolaryngology Doctors in Astoria
Dr. Russell Beckhardt, M.d, M.D
Otolaryngology — Payments: $4,488
Otolaryngology $4,488
Dr. Steven Alexander, M.d, M.D
Otolaryngology — Payments: $2,948
Otolaryngology $2,948
Andres Lopez-Albaitero, Md, MD
Otolaryngology — Payments: $2,142
Otolaryngology $2,142
Justin Holt, Md, MD
Otolaryngology — Payments: $640.93
Otolaryngology $640.93
Mr. Robert Molle, Md, MD
Otolaryngology — Payments: $171.48
Otolaryngology $171.48
Dr. Roger Miller, M.d, M.D
Otolaryngology
Otolaryngology